315 related articles for article (PubMed ID: 25791157)
1. NSAID-induced small intestinal damage--roles of various pathogenic factors.
Takeuchi K; Satoh H
Digestion; 2015; 91(3):218-32. PubMed ID: 25791157
[TBL] [Abstract][Full Text] [Related]
2. Factors involved in upregulation of inducible nitric oxide synthase in rat small intestine following administration of nonsteroidal anti-inflammatory drugs.
Takeuchi K; Yokota A; Tanaka A; Takahira Y
Dig Dis Sci; 2006 Jul; 51(7):1250-9. PubMed ID: 16944022
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic importance of intestinal hypermotility in NSAID-induced small intestinal damage in rats.
Takeuchi K; Miyazawa T; Tanaka A; Kato S; Kunikata T
Digestion; 2002; 66(1):30-41. PubMed ID: 12379813
[TBL] [Abstract][Full Text] [Related]
4. Exacerbation of nonsteroidal anti-inflammatory drug-induced small intestinal lesions by antisecretory drugs in rats: the role of intestinal motility.
Satoh H; Amagase K; Takeuchi K
J Pharmacol Exp Ther; 2012 Nov; 343(2):270-7. PubMed ID: 22854201
[TBL] [Abstract][Full Text] [Related]
5. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
[TBL] [Abstract][Full Text] [Related]
6. Induction of small intestinal damage in rats following combined treatment with cyclooxygenase-2 and nitric-oxide synthase inhibitors.
Ohno R; Yokota A; Tanaka A; Takeuchi K
J Pharmacol Exp Ther; 2004 Aug; 310(2):821-7. PubMed ID: 15044560
[TBL] [Abstract][Full Text] [Related]
7. Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.
Satoh H; Amagase K; Takeuchi K
J Pharmacol Exp Ther; 2014 Feb; 348(2):227-35. PubMed ID: 24254524
[TBL] [Abstract][Full Text] [Related]
8. Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage.
Takeuchi K; Tanaka A; Kato S; Amagase K; Satoh H
Clin Chim Acta; 2010 Apr; 411(7-8):459-66. PubMed ID: 20074562
[TBL] [Abstract][Full Text] [Related]
9. Functional mechanism underlying cyclooxygenase-2 expression in rat small intestine following administration of indomethacin: relation to intestinal hypermotility.
Tanaka A; Matsumoto M; Hayashi Y; Takeuchi K
J Gastroenterol Hepatol; 2005 Jan; 20(1):38-45. PubMed ID: 15610444
[TBL] [Abstract][Full Text] [Related]
10. Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage.
Takeuchi K; Tanaka A; Ohno R; Yokota A
J Physiol Pharmacol; 2003 Dec; 54 Suppl 4():165-82. PubMed ID: 15075458
[TBL] [Abstract][Full Text] [Related]
11. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
[TBL] [Abstract][Full Text] [Related]
12. NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same?
Fornai M; Antonioli L; Colucci R; Pellegrini C; Giustarini G; Testai L; Martelli A; Matarangasi A; Natale G; Calderone V; Tuccori M; Scarpignato C; Blandizzi C
J Pharmacol Exp Ther; 2014 Jan; 348(1):86-95. PubMed ID: 24135073
[TBL] [Abstract][Full Text] [Related]
13. Role of dietary fibres, intestinal hypermotility and leukotrienes in the pathogenesis of NSAID-induced small intestinal ulcers in cats.
Satoh H; Shiotani S; Otsuka N; Hatao K; Nishimura S
Gut; 2009 Dec; 58(12):1590-6. PubMed ID: 19060018
[TBL] [Abstract][Full Text] [Related]
14. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study.
Maiden L; Thjodleifsson B; Seigal A; Bjarnason II; Scott D; Birgisson S; Bjarnason I
Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1040-5. PubMed ID: 17625980
[TBL] [Abstract][Full Text] [Related]
15. Detection and prevention of NSAID-induced enteropathy.
Davies NM; Saleh JY; Skjodt NM
J Pharm Pharm Sci; 2000; 3(1):137-55. PubMed ID: 10954683
[TBL] [Abstract][Full Text] [Related]
16. Cinacalcet, a calcimimetic, prevents nonsteroidal antiinflammatory drug-induced small intestinal damage in rats.
Hayashi S; Kurata N; Kitahirachi E; Nishimura Y; Amagase K; Yano T; Takeuchi K
J Physiol Pharmacol; 2013 Aug; 64(4):453-63. PubMed ID: 24101391
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic effects of prostaglandin E2 on NSAID-induced enteropathy-role of EP4 receptors in its protective and healing-promoting effects.
Takeuchi K
Curr Opin Pharmacol; 2014 Dec; 19():38-45. PubMed ID: 25063918
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of NSAID-induced gastric damage: importance of cyclooxygenase inhibition and gastric hypermotility.
Takeuchi K
World J Gastroenterol; 2012 May; 18(18):2147-60. PubMed ID: 22611307
[TBL] [Abstract][Full Text] [Related]
19. Distribution of small intestinal mucosal injuries as a result of NSAID administration.
Fujimori S; Gudis K; Takahashi Y; Seo T; Yamada Y; Ehara A; Kobayashi T; Mitsui K; Yonezawa M; Tanaka S; Tatsuguchi A; Sakamoto C
Eur J Clin Invest; 2010 Jun; 40(6):504-10. PubMed ID: 20412292
[TBL] [Abstract][Full Text] [Related]
20. Role of dietary fiber in formation and prevention of small intestinal ulcers induced by nonsteroidal anti-inflammatory drug.
Satoh H
Curr Pharm Des; 2010; 16(10):1209-13. PubMed ID: 20166992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
